Current position

Ray Dalio’s Adient Plc (ADNT) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2019Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares432.44KHighest verified quarter-end share count
Quarters reported14Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Adient Plc in Q4 2019. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 378.87K shares. The latest verified filing showed: Bought 30.6% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 30.6% more+88.77K shares · 378.87K shares reported after the change
Filing context

Quarter-end price $18.38 · Estimated holding basis $22.74

Q1 2026
Sold 32.4% of the position−139.18K shares · 290.10K shares remained
Filing context

Quarter-end price $20.21 · Estimated holding basis $24.08

Q4 2025
Sold 0.7% of the position−3.16K shares · 429.28K shares remained
Filing context

Quarter-end price $19.17 · Estimated holding basis $24.08

Q3 2025
New position+432.44K shares · 432.44K shares reported
Filing context

Quarter-end price $24.08 · Estimated holding basis $24.08

Q3 2022
Sold the entire position−66.12K shares · No shares reported at quarter-end
Q2 2022
Sold 3.3% of the position−2.27K shares · 66.12K shares remained
Filing context

Quarter-end price $29.63 · Estimated holding basis $43.22

Portfolio importance

How important is Adient Plc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#407of 997 reported positions
Peak portfolio weight0.0%Q3 2025
Best historical rank#231Q1 2021
At peak importanceQ3 2025
ADNT
0.0%
Largest holding
10.6%
Cross-investor discovery

Who else owns Adient Plc?

Also reported by 1 other tracked investor in their latest verified filings.

Explore Adient Plc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$18.372026-09-15

Market context only; not an investor transaction price.

Latest filing quarter-end price$18.38Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$22.74Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.